9thAnnual Conference on

Clinical Research & Biomarkers

Theme: Recent Developments & Innovations in Biomarkers Research

Event Date & Time

Event Location

Amsterdam, Netherlands

18 years of lifescience communication

14422635477

Previous Conference Performers / Professionals From Around The Globe

Conference Speaker

Diana Foster

Total Clinical Trial Management
USA

Conference Speaker

Marina Guvakova

University of Pennsylvania
USA

Conference Speaker

Wassil Nowicky

Ukrainian Anti-Cancer Institute
Austria

Conference Speaker

Youhe Gao

Beijing Normal University
China

Conference Speaker

Kenji Izuhara

Saga Medical School
Japan

Conference Speaker

Zuzana Horakova

St. Annes University Hospital
Czech Republic

Conference Speaker

Violet Kasabri

The University of Jordan
Jordan

Conference Speaker

Suha Al Muhaissen

The University of Jordan
Jordan

Conference Speaker

Nwayyin Mohammed

University of Sulaymaniyah
Iraq

Conference Speaker

Maysa Suyagh

The University of Jordan
Jordan

Conference Speaker

Charles Businge

University of Cape Town
South Africa

Tracks & Key Topics

Clinical Research & Biomarkers 2019

About Conference

EuroSciCon extends its warm welcome to all its participants to Clinical Research & Biomarkers 2019 scheduled on March 7-8, 2019 at Amsterdam, Netherlands with a theme “The Current Aspects and The Future of Clinical Research and Biomarkers". EuroSciCon organizes Global Events with Conferences, Symposiums and Workshops on Medical, Pharma, Engineering, Science, Technology and Business.           

We gladly welcome attendees all around the world for the hearing of the foremost recent innovations and inventions in the field of Clinical Research and Biomarkers. This Conference will provide a forum for exchange of ideas and authoritative views by leading scientists, industry specialists and from the academicians of the best institutes from around the globe. Outstanding keynote speakers and well known leading scientists and experts from around the globe will be expected to share their knowledge and talk about various aspects related to various frontiers in the field if Biomarkers and Clinical Research.    

Our aspiration is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the knowledge that’s still more to be revealed. Gain and grab the knowledge. Conferences and symposia provide unlimited opportunities to strengthen the community and are also the collective body of knowledge.  We cordially encourage you to attend and contribute to one of the major events of 2019 on the field of Clinical Research and Biomarkers.  The conference will reveal the present and future aspects in the field of Clinical Research and Biomarkers which are the need of the hour for instant and précised treatment.

Conference Topics:

  • Biomarkers & Research
  • Role of Biomarkers in Translational Science
  • Precision Medicine & Clinical Diagnostics
  • Biomarker Assay Validation & Patient Stratification            
  • Biomarker Clinical Trials & Developments
  • Biomarker Development - Omics Technologies
  • Biomarkers for non-invasive diagnostics
  • Biomarkers in Drug Discovery
  • Biomarkers for Cancer Screenings
  • Types of cancer biomarkers
  • Uses of biomarkers in various areas
  • Circulating Biomarker Classes
  • Biomarkers development in Therapeutic Areas
  • Innovations in Biomarkers Research
  • Extracellular Vesicle-based Biomarkers
  • Research Tools
  • Types of Biomarkers in Cancer Detection
  • Case studies
  • Exploring, identifying & validating new biomarkers          
  • CRO & Sponsorship
  • Careers in Clinical Research
  • Pharmacovigilance & Drug Safety
  • Clinical Trial Supply Management

Clinical Research & Biomarker:

The branch of health care determines safety & efficacy of medications, devices, diagnostics and treatments intended for human use is termed Clinical Research These are used for the treatment purpose, prevention, diagnosis and relieving symptoms of the diseases. Clinical research varies from clinical practice. Clinical practice uses established, whereas in case of clinical research evidence is collected for establishing the new treatment. And “biological marker” i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient and is measured accurately.      

Who and Why??

Biomarkers & Clinical Research 2019 Conference brings together the specialists from all the aspects to meet and discuss the future of Clinical Research and Importance of Biomarkers in today’s world to thrive and survive with a better health. The conference will bring together  Directors, Doctors, Director of Laboratories, Universities, Industries, Delegates, Clinical Research specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, CRO’s, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies, Medical device specialist and all the interested participants willing to enhance and update the knowledge on Biomarkers and Clinical Research. 

   

Scope and Importance:

The global clinical trial management system market is valued at the estimated USD 534.0 Million in the year 2016 and is projected to grow at CAGR of 11.5% during forecast period of 2016-2021, to reach USD 920.0 Million by the year 2021. The growth in this market is driven primarily by factors as increasing R&D expenditure of life science and clinical research industries, rise in number of clinical trials, and increasing adoption of CTMS solutions. On the other hand, factors such as lack of skilled professionals for operating advanced CTMS solutions and budget constraints of small and medium sized pharmaceutical and biotechnology companies and small CROs are restraining growth of the global clinical trial management system.         

For Researchers & Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

Sessions/Tracks

Biomarkers & Research

Biomarkers are the particles which demonstrate ordinary/anomalous process occurring in the body and may be the indication of a hidden condition or sickness. Different kinds of atoms can fill in as biomarkers, for example, DNA (genes), proteins or hormones since they all demonstrate the status of your wellbeing. Biomarkers participate in different procedures like diagnosis and prognosis, expectation and estimation of treatment reaction, and security assessment. The atomic biomarkers are solely being created and approved to be utilized as a part of medication improvement and are utilized to help endorsement of medication items.

  • Molecular biomarkers
  • Cancer biomarkers
  • Lipid biomarkers
  • Oncology biomarkers
  • Neurological biomarkers
  • Inflammatory & immunological biomarkers
  • Cardiovascular biomarkers
  • In-silico biomarkers
  • Pathological biomarkers

Role of Biomarkers in Translational Science

In the post-genomic time, it has turned out to be obvious that hereditary changes alone are not adequate to see most sickness forms including tumor. Genome sequencing has uncovered an unpredictable arrangement of hereditary changes in disease, for example, point transformations, chromosomal misfortunes, quality intensifications and telomere shortening that drive harmful development through specific signalling pathways. Proteome-based methodologies are vital supplements to genomic information and give essential data of the objective driver particles and their post-translational changes. By applying quantitative mass spectrometry, this is an elective method to distinguish biomarkers for early diagnosis and personalized medicine.

  • Improving cancer patient care through translational science
  • Safety, efficacy and PK/PD biomarkers in drug development
  • Biomarkers for early identification of neurological disease
  • Biomarker development in metabolic and cardiovascular diseases
  • Predictive biomarkers for drug development
  • Translating biomarkers from discovery stages through to exploratory clinical testing
  • New advances in biomarker technologies and platform

Precision Medicine & Clinical Diagnostics

Personalized Medicine is known for its utilization of genomic data notwithstanding the family history, natural components and way of life to deal with the health. Exact expectations can be made about a man's weakness to building up an illness, the course of the ailment and to react to the treatment. Customized Medicine is another field of research and confirmation-based writing is required for incorporating into social healthcare delivery.

  • Personalised healthcare: translating scientific innovation into patient benefit
  • The future of targeted therapy and precision medicine
  • Updates on companion diagnostics development
  • The impact of patient self-monitoring in healthcare
  • Challenges of drug & diagnostics co-development

Biomarker Assay Validation & Patient Stratification

Biomarker inquire about is a consistent procedure starting with revelation and then continues to approval process till the usage of biomarkers in the clinical setting. Hopeful biomarkers which are distinguished in disclosure organize should be approved over the quantity of tests. The test is to build up a quick and focused on investigation strategy that is equipped for dissecting whatever number recognized competitors as would be prudent in least hundred and possibly even a huge number of tests. Biomarker competitors distinguished amid revelation process are approved utilizing bigger examples which covers a wide area of patients. The check organize gives affirmation that a specific philosophy is reasonable to be utilized as a part of the validation stage.

  • Biomarkers in Patient Stratification and Translation
  • Microbiome Biomarkers for Parkinson’s disease
  • PDX – Patient Derived Xenograft models for Biomarkers
  • Companion and clinical diagnostics development as well as patient testing
  • Biomarker assay validation

Biomarker Clinical Trials & Developments

The significant utilization of biomarkers in clinical examination is as clinical trials & monitoring. The whole range of infection from the soonest sign till the terminal stages might be reverberated through these biomarkers. Biomarker demonstrates the best connection between its reaction when it is contrasted with the wellbeing/biological impact. It gives assortment of human and creature materials chiefly through immuno-measures and quantitative PCR that can be diagnostically decided at any of the Biomarker Laboratory.
  • Overcoming challenges of clinical validation & translation
  • Advances in mass spectrometry, flow cytometry, digital pathology & imaging
  • Overcoming data handling and big data challenges
  • Implementing clinical biomarker in auto-immune diseases
  • Advancing clinical data and precision medicine
  • Surrogate endpoints: utilising biomarkers in clinical trials
Biomarker Development - Omics Technologies
 
 
In recent years, the utilization of high-throughput omics advances has prompted the fast revelation of numerous hopeful biomarkers. Notwithstanding, few of them have made the progress to the facility. In this survey, the guarantee of omics advances to add to the procedure of biomarker improvement is depicted. A diagram of the present state around there is given cases of genomics, proteomics, transcriptomics, metabolomics and micro biomics biomarkers in the field of oncology, alongside some proposed systems to quicken their approval and interpretation to enhance the care of patients with neoplasms. The inherent complexity underlying neoplasms joined with the prerequisite of growing all around planned biomarker disclosure forms in view of omics advancements introduce a test for the compelling improvement of biomarkers that might be helpful in managing treatments, tending to illness hazards, and anticipating clinical results.
  • Transforming clinical development through biomarker driven clinical trials design
  • The use of proteomic and metabolomic biomarkers in the clinic
  • NGS & Genomic Marker Development
  • Translating CTCs and ctDNA for Clinical Use
  • The importance of liquid biopsies for precision medicine in cancer
  • microRNA, cfDNA as Emerging Biomarkers
Biomarkers for non-invasive diagnostics
 
 
There is developing logical enthusiasm for the examination of metabolomics and quantities of studies have concentrated on the use of non-intrusive biomarkers in the determination.
  • Circulating free tumour DNA
  • Circulating micro RNA
  • Circulating Tumour Cells
  • Fluid & Blood Biopsy Biomarkers
  • Non-Invasive Prenatal Testing

Biomarkers in Drug Discovery

Biomarkers of illness assume a critical part in prescription and have started to accept a more prominent part in medicate disclosure and advancement. The test for biomarkers is to permit prior, more powerful medication wellbeing and adequacy estimations. Their part in tranquilize advancement will keep on growing for years to come. For biomarkers to accept their legitimate part, more prominent comprehension of the instrument of ailment movement and helpful intercession is required. What's more, more noteworthy comprehension of the prerequisites for biomarker choice and approval, biomarker examine strategy approval and application, and clinical endpoint approval and application is required. Biomarkers should be considered while the remedial target is yet being distinguished and the idea is being defined.
  • Precision Medicine in Auto-Immune Diseases
  • Translation medicine in CNS
  • Medicine Development in Oncology and Infectious Diseases
  • Drug discovery innovation and strategies
  • Phenotypic and genomic drug discovery
  • Computational chemistry and informatics for drug discovery
Biomarkers for Cancer Screenings
 
 
Screening for early invasive disease has the potential to reduce mortality from cancer. Because of their ease of measurement, several biomarkers have been evaluated or are currently undergoing evaluation as screening tests for early cancer. These include the use of biomarkers in screening for cancer in high-risk subjects. Although biomarkers have many attractive features as cancer screening tests, lack of sensitivity and specificity, when combined with the low prevalence of specific cancer types in asymptomatic subjects, limit their application for the early detection of cancer.
  • Breast cancer screening 
  • Cervical cancer screening 
  • Bowel cancer screening 
  • Prostate cancer screening 
  • Lung cancer screening 
  • Pancreatic cancer screening
Types of cancer biomarkers
 
 
There are numerous types of cancer biomarkers, and they each work contrastingly inside the body and respond diversely to medicines. In general, cancer biomarkers are grouped by their distinctive capacities. Tumor biomarkers can incorporate, proteins, gene transformations & changes, gene adjustments, extra duplicates of genes, missing genes and other molecules.
  • Lung cancer biomarkers 
  • Prostate cancer biomarkers 
  • Breast cancer biomarkers
  • Biomarkers for Alzheimer
  • Advanced biomarkers for cancer 
Uses of biomarkers in various areas
 
 
Biomarkers give a dynamic and ground-breaking way to deal with understanding the range of neurological sickness with applications in observational and explanatory the study of disease transmission, randomized clinical trials, screening and diagnosis and prognosis. Characterized as adjustments in the constituents of tissues or body liquids, these markers offer the methods for homogeneous arrangement of a malady and hazard factors, and the can expand our base data about the fundamental pathogenesis of ailment. Biomarkers can likewise mirror the whole range of malady from the soonest signs to the terminal stages.
  • Uses of biomarkers in cancer medicine 
  • Uses of Molecular or Biochemical Biomarkers
  • Uses of Physiologic biomarkers
  • Uses of Anatomic biomarkers
Circulating Biomarker Classes
 

Circulating biomarkers incorporates markers as straightforward as glucose or cholesterol and also protein biomarkers, for example, C-responsive protein (CRP), circling without cell DNA (cfDNA), or flowing RNA. In more up to date cases, it likewise incorporates qualities, for example, BCRA1, KRAS, and others. As of late, the field has extended to incorporate coursing tumor cells (CTCs) and exosomes or extracellular vesicles (EVs). Circling biomarker examine thinks about spotlight on a few analyte classes/gatherings. As of late, there has been expanding enthusiasm for a couple of these classes.

  • Exosomes
  • Microvesicles
  • Circulating-Free DNA (cfDNA)
  • Circulating RNA
  • Circulating Tumor Cells (CTCs)

Biomarkers development in Therapeutic Areas

Biomarkers have a few uses in pharmaceutical Research and Development. With the ongoing presentation of superior instrumentation, protein and gene clusters and bioinformatics, clinical choices like Drug improvement and picking sort of treatment can be made productively. Be that as it may, there is an absence of legitimate biomarkers to expand the medication advancement from pre-clinical through all levels of clinical investigations. Biomarker in Drug Discovery can likewise prompt improvement of Personalized Medicines. Biomarkers empower quantitation of the degree to which new medications achieve planned targets, adjust proposed pathophysiological instruments and accomplish clinical results. The Biomarkers challenge is to distinguish exceptional sub-atomic marks in complex organic blends that can be unambiguously associated to natural occasions keeping in mind the end goal to affirm novel medication targets and anticipate sedate reaction. Biomarkers can measure medicate help with essential evasion or sickness alteration examines or to isolate persistent populaces in deficiently served locales, for example, neurodegeneration and cancer. Clinically important biomarkers are required to tell administrative and medicinal basic leadership to new medications and their signs keeping in mind the end goal to pass on new pharmaceuticals to the correct patients speedier than they are today.
  • Cardiovascular
  • Rheumatology
  • Respiratory
  • COPD
  • Rare Diseases
  • Infectious Diseases
  • Inherited Diseases
Innovations in Biomarkers Research
 
 
The advancements in the field of biomarkers has been a brilliant development. Different new advancements and explores been occurring for more extension of the innovation. Imaging to screening, all needs more extensive development too.
  • Assay Development
  • Imaging
  • Bioinformatics
  • Trial Design
  • Data Management
  • Imaging Technologies
Extracellular Vesicle-based Biomarkers
 
 
The presence of contaminants in EVs segregated by the customary strategies recorded meddles with mass spectrometry and is a noteworthy hindrance in exosome molecular profiling and biomarker contemplates.
  • Exosomes and Micro vesicles in Biological Fluids
  • Liquid Biopsies for Inherited Diseases
  • Fluid & Blood Biopsy Biomarkers
  • Examples of Translation into the Clinic
Research Tools
 
 
A biomarker is a characterized trademark that is utilized as a marker of typical organic procedures, pathogenic procedures or reactions to a restorative intercession. Biomarkers are perceived as basic tools for the development of therapeutics, permitting enhanced and better educated clinical trial outline through pointers of target commitment and those that empower tolerant stratification. Moreover, biomarkers can encourage the assessment of helpful mediation on malady movement or repeat. Even though biomarker disclosure is an exceptionally dynamic research zone, few biomarkers have been adequately approved for use in clinical practice or clinical trials.
  • Methodologies and Applications
  • Isolation
  • Capture
  • Biomarker Cargo Analysis

Types of Biomarkers in Cancer Detection

There are a several kinds of biomarkers, which satisfy distinctive parts over the continuum of care. By dissecting biomarkers, symptomatic tests might have the capacity to give data about early tumor improvement to identify cancer at an early, more treatable stage. These biomarkers can be useful in curing patients in different various settings.
  • Risk Assessment 
  • Screening/Detection
  • Diagnosis
  • Prognosis
  • Prediction
  • Monitoring
Case studies
 

Biomarkers are proposed to replace surrogate endpoints in clinical preliminaries process. Surrogate markers are utilized to direct the clinical trial and assemble a few endpoints which is illogical when the essential endpoint is undesired, or the occasion number is little. Biomarkers help in the diagnostics and clinical advancement forms. Biomarkers contextual analysis assumes a vital part in finding new medications for the patients who require new medications and to be utilized broadly in different clinical practices.

  • MicroRNA’s
  • CTCs
  • Circulating free DNA
  • Exosomes
  • Biomarker to Diagnostic

Exploring, identifying & validating new biomarkers

Biomarker classification depends on its context of utilization, which thoroughly characterizes the degree to which the biomarker must be "validated." as far as necessities for approval, the "blessed vessel" of biomarker application is one that can fill in as a surrogate endpoint in a clinical trial. A surrogate endpoint is a research facility (or physical) estimation that is utilized as a part of a clinical trial as a substitute for a clinical endpoint (e.g., survival or practical endpoint). Subsequently, a surrogate endpoint should precisely anticipate the impact of therapeutic intervention.
  • Collaborating with other disciplines
  • Non-invasive & least-invasive Biomarkers
  • The Latest Oncology Diagnostics
  • Informatics in Personalized Medicine
  • Novel approaches to drug design
  • Application of Genetics/Genomics in the Clinic
CRO & Sponsorship
 
 
CRO offers help to the pharma businesses as research administrations outsourced on contract premise. In the lead of clinical preliminaries, a support is an individual/ foundation/ organization/ association that assumes liability to start, oversee or back clinical preliminary, however it doesn't direct the examination. The support is obligation is for actualizing and keeping up QA and QC frameworks with composed SOPs to guarantee that preliminaries are directed, and information is produced, archived, and announced in consistence with the convention, GCP, and the pertinent administrative prerequisite.
  • Business development tactics
  • Strategies to attract sponsors
  • Clinical Trials for Small Sponsors
  • Evolving Strategic Partnerships
  • Patient-pharma relationship CR
Careers in Clinical Research
 
 
The clinical trials are the logical investigations of impacts, dangers, viability and advantages of new and notwithstanding existing drugs. Trials should be completed before an item achieves the healing centre or nearby drug store. They are attempted at different stages, or say 'stages', and incorporate trials on solid people; patients with an ailment; and likewise thinks about directed after the dispatch of the new item to screen wellbeing and symptoms amid huge scale utilize. Clinical preliminaries are directed by pharmaceutical organizations or Contract Research Organizations for their sake. There are different parts and duties in these periods of Clinical Trials.
  • Clinical CROs 
  • BA/BE Centers
  • SMOs 
  • Data Management 
  • IT Companies in Healthcare/Clinical Domains
  • Central Laboratories
  • Packaging & Labeling
  • Investigator & Site Staffs
Pharmacovigilance & Drug Safety
 
 
Pharmacovigilance and Risk Management was intended for giving a comprehension of hazard administration in human services activities and applications. Pharmacovigilance is characterized as the science and the exercises identifying with the recognition, evaluation, understanding and even counteractive action of unfriendly impacts or some other medication related issue. The points of PV is to improve quiet care and patient wellbeing in connection to use of drugs.
  • Ecopharmacovigilance
  • PV: Current Regulation & Challenges
  • Pharmacovigilance and Risk Management
  • Pharmacovigilance Significance & Scope
  • PV Consulting’s and Business opportunity
  • Adverse Drug Reactions

Clinical Trial Supply Management

In-house treatment of clinical preliminaries can now and again be a managerial and functional weight. By halfway outsourcing clinical preliminary dispersion, pharmaceutical research associations will frequently have the capacity to free up interior assets and in the meantime improve security and nature of the conveyance of their preliminary drug. It can help in various stages like:
  • Forecasting 
  • Stock Management 
  • IRT Med Management 
  • Temperature Services 
  • Mass Drug Management 
  • Examiner Initiated Trials and Specialized Clinical Programs
  • Drug store Services

Learn More

Clinical Research & Biomarkers Universities in USA:

Arizona State University | Augusta University | Washington University | Campbell University | Cleveland Clinic | CUNY Hunter College | Brigham and Women's Cancer Center | Drexel University | Eastern Michigan University | Fairleigh Dickinson University | George Washington University | Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia | Johns Hopkins Hospital | Massachusetts General Hospital | Mayo ClinicMinnesota MCPHS University | Memorial Sloan Kettering Cancer Center | Moffitt Cancer Center and Research Institute New York–Presbyterian University Hospital of Columbia and Cornell | Northwestern Memorial HospitalOhio State University | Regis College | Saint Cloud State University | San Jose State University | Seattle Cancer Care Alliance | University of Washington Medical Center Stanford Health Care-Stanford Hospital | The University of Texas Health Science Center at Houston | Thomas Jefferson University | UCLA Medical Center | UCSF Medical Center | University of California San Diego | University of Louisville | University of North Carolina Hospitals University of North Carolina Wilmington | University of North Carolina-Chapel Hill | University of North Texas | University of St Thomas | University of Texas MD Anderson Cancer Center | University of Texas Medical Branch | University of Texas Rio Grande Valley | University of Vermont | University of Virginia | USC Norris Cancer Hospital-Keck Medical Center of USC | Wake Forest Baptist Medical Center

Clinical Research & Biomarkers Universities in Europe:

Cancer Research UK Cambridge Research Institute | Cardiff University | Christie Hospital NHS Foundation Trust | Danish Cancer SocietyInstitute of Cancer Biology | Ecole Polytechnique Fédérale de Lausanne | Erasmus Medical Centre | ETH Zürich (Swiss Federal Institute of Technology) | European CanCer Organisation European Cancer Patient Coalition | European Institute of Oncology (IEO) European Molecular Biology Laboratory European Organisation For Research and Treatment of Cancer | Fundacion Instituto Valenciano de Oncologia (IVO) | German Cancer Research Centre  | Imperial College London | Institut Curie  | Institut Gustave Roussy  | Institut Jules BordetCentre des Tumeurs de l'Universite Libre de Bruxelles | Institute of Cancer Research - Royal Marsden Hospital | International Agency for Research on Cancer | Istituto Nazionale dei Tumori | Istituto Tumori Giovanni Paolo II |Karolinska Institutet  | King’s College London | Leiden University Medical Centre | Maastricht University | National Institute of Oncology  | Netherlands Cancer Institute | Newcastle University | Organisation of European Cancer Institutes | Oslo Comprehensive Cancer CentreQueen Mary University of London | Queen’s University Belfast | Spanish National Cancer Centre  | Technische Universität München | The University of Manchester | Trinity College Dublin | Universität Zürich | Université de Genève | University College Dublin | University College London | University of Birmingham | University of Bristol | University of CopenhagenUniversity of Edinburgh | University of Glasgow | University of Groningen | University of Liverpool | University of Nottingham | University of Oxford | University of Southampton | University of St. Andrews | University of Warwick | University of York | Vall d'Hebron Institute of Oncology

Clinical Research & Biomarkers Universities in Asia:

The University of Tokyo | National University of Singapore (NUS) | Kyoto University | University of Hong Kong (HKU) | Peking University | Seoul National University (SNU) | National Taiwan University (NTU) | Osaka University | Tsinghua University | The Chinese University of Hong Kong (CUHK) | Fudan University | The Hong Kong University of Science and Technology (HKUST) Taipei Medical University | Mahidol University | KAIST - Korea Advanced Institute of Science and Technology | Yonsei University | Shanghai Jiao Tong University | Nanyang Technological University (NTU) | Chulalongkorn University | Tohoku University | Tokyo Medical and Dental University | Kyushu University | Nagoya University | Hokkaido University | Sungkyunkwan University University of Science and Technology of ChinaPohang University of Science and Technology (POSTECH) Korea University | Universiti Malaya (UM) | Zhejiang University | Keio University | Indian Institute of Science | Tokyo Institute of Technology | Universiti Kebangsaan Malaysia (UKM) | Universiti Sains Malaysia (USM) | Beijing University of Chinese Medicine | National Tsing Hua University | Nanjing University | Kyung Hee University | National Yang Ming University | University of Indonesia | University of the Philippines | University of Tsukuba | Bandung Institute of Technology (ITB) | Hanyang University | Indian Institute of Technology Bombay (IITB) | National Cheng Kung University | Universiti Putra Malaysia (UPM) | Beijing Institute of Technology University of Delhi

Clinical Research & Biomarkers Societies in USA:

ACRP: Association of Clinical Research Professionals  | American Association for Cancer Research  | American Cancer Society  | American Cancer Society  | American Cancer Society Cancer Action Network  | American Federation for Medical Research: AFMR  | American Society of Clinical Oncology   | American Society of Clinical Oncology | ASCO  | Anxiety and Depression Association of America, ADAA  | Association of Clinical Research Organizations  | Association-Clinical Research | CGD Society - Clinical trials  | Clinical Research Association of Canada  | Clinical Trials - Alzheimer's Association  | Clinical Trials - MPS Society  | Clinical Trials – Society for Women's Health Research  | American Thyroid Association  | Clinical Trials | Leukemia and Lymphoma Societ  | Clinical Trials | National CML Society Clinical Trials Veterinary Cancer Society  | Clinical Trials Network | SNMMI  | Clinical Trials: American Diabetes Association  | CRS : Clinical Research Society | DIA - Clinical Research - Drug Information Association  | Dysphagia Research Society  | Dystonia Medical Research Foundation | DMRF  | International Association of Clinical Research Nurses  | National Brain Tumor Society  | Osteoarthritis Research Society International (OARSI)  | Society for Clinical Data Management (SCDM)  | Society for Clinical Trials (SCT)  | SOCRA The Society of Clinical Research Associates  | T21RS  | The American Society of Hematology  | USA & Canada - Society of Clinical Research Associates  | American Association for Cancer Research  | American Breast Cancer Foundation

Clinical Research & Biomarkers Societies in Europe:

The European Association for Clinical Pharmacology and Therapeutics (EACPT)   | Academy of Physicians in Clinical Research  | Association of European Cancer Leagues (ECL) | Association of Medical Research Charities: AMRC  | Breast International Group (BIG) | Cardiovascular and Interventional Radiological Society of Europe (CIRSE) | DIA - Clinical Research - Drug Information Association  | EACR - European Association for Cancer Research  | ECFS Clinical Trials Network  | ECRIN: Facilitating European Clinical Research  | ENGOT  | ESA Clinical Trial Network  | ESCMID  ESDR: European Society for Dermatological Research  | ESMO: European Society for Medical Oncology  | ESPR European Society for Paediatric Research   | European Association for Cancer Research (EACR) | European Association of Neuro-Oncology (EANO) | European Association of Nuclear Medicine (EANM) |European Association of Urology (EAU) | European CanCer Organisation: ECCO  | European Oncology Nursing Society (EONS) | European Organisation for Research and Treatment of Cancer (EORTC) | European School of Oncology (ESO) | European Sleep Research Society   | European Society for Clinical Investigation  | European Society for Medical Oncology (ESMO) | European Society for Paediatric Oncology (SIOPE) | European SocieTy for Radiotherapy and Oncology (ESTRO) | European Society for Surgical Research | European Society of Breast Cancer Specialists (EUSOMA) | European Society of Coloproctology (ESCP) | European Society of Gynaecological Oncology (ESGO) | European Society of Oncology Pharmacy (ESOP) | European Society of Pathology (ESP) | European Society of Radiology (ESR) | European Society of Skin Cancer Prevention (EUROSKIN) | European Society of Surgical Oncology (ESSO) | European Society of Surgical Oncology European Oncology Nursing Society | ICTA (International Clinical Trials Association)  | International Psycho-Oncology Society (IPOS)  | International Society of Geriatric Oncology (SIOG) | Organisation of European Cancer Institutes (OECI)

Clinical Research & Biomarkers Societies in Asia:

Association of Oncologists of Uzbekistan |  Chinese Society of Clinical Oncology (CSCO) |  Hong Kong Cancer Therapy Society |  Indian society clinical research |  Indian Society of Medical & Paediatric Oncology (ISMPO) |  Indonesian Society of Hematology and Medical Oncology (ISHMO) |  Iranian Cancer Association (ICA) |  Iranian Society of Clinical Oncology (ISCO) |  Middle-Eastern Association for Cancer Research (MEACR) |  Iranian Society of Medical Oncology and Hematology (ISMOH) |  Japan Society of Clinical Oncology (JSCO) |  Japanese Society of Medical Oncology (JSMO) |  Korean Association for Clinical Oncology (KACO) |  Malaysian Oncological Society |  Medical Oncology Group of Australia (MOGA) |  Myanmar Oncology Society |  New Zealand Association of Clinical Research |  New Zealand Society for Oncology (NZSO) |  Oncology Club, Bangladesh |  Pakistan Society of Clinical Oncology (PSCO) |  Philippine Society of Medical Oncology (PSMO) |  Singapore Society of Oncology (SSO) |  Taiwan Oncology Society (TOS) |  Thai Society of Clinical Oncology (TSCO)

Clinical Research & Biomarkers Journals:

Journal of Clinical & Cellular Immunology | Journal of AIDS & Clinical Research | Journal of Clinical & Experimental Dermatology Research Journal of Clinical Toxicology | Journal of Clinical & Experimental Cardiology | Clinical Investigation | Journal of Clinical Research & Bioethics | Journal of Clinical & Experimental Pathology | Journal of Clinical & Experimental Ophthalmology | Archives of Clinical Microbiology | Journal of Clinical TrialsClinics in Mother and Child Health | Journal of Anesthesia  & Clinical Research | Journal of Clinical Case Reports | Clinical Research on Foot & Ankle | Clinical Practice (Therapy) | Journal of Clinical & Experimental Pharmacology | Clinical Microbiology: Open Access | American Journal of Phytomedicine and Clinical Therapeutics | Clinical Pharmacology & Biopharmaceutics | Journal of Clinical & Medical Genomics | Journal of Traditional Medicine & Clinical Naturopathy | Journal of Clinical & Experimental Oncology |Journal of Clinical and Molecular Endocrinology | Clinical Psychiatry | Journal of Clinical Respiratory Diseases and Care | International Journal of Clinical & Medical Imaging | JBR Journal of Clinical Diagnosis and Research | Research & Reviews: Journal of Hospital and Clinical Pharmacy | Clinical & Medical Biochemistry | Clinical and Experimental Psychology | Journal of Clinical and Experimental Transplantation | Journal of Clinical Nutrition & Dietetics | Journal of Clinical & Experimental Neuroimmunology | Journal of Clinical Infectious Diseases & Practice | Journal of Clinical and Medical Case Studies | Clinical Depression | Journal of Clinical & Experimental Orthopaedics Journal of Clinical Developmental Biology | Journal of Cancer Clinical Trials | Clinical Pediatric Dermatology | Medical & Clinical Reviews | Journal of Neuroscience & Clinical Research | Annals of Clinical and Laboratory Research | Research & Reviews: Medical and Clinical Oncology | Journal of Medical Toxicology and Clinical Forensic Medicine | International Journal of Clinical Skills | Clinical Pediatrics: Open Access | Journal of Clinical Epigenetics | Journal of Clinical & Experimental NephrologyJournal of Vaccines & Clinical Trials | Breast Cancer: Current Research |  Advances in Cancer Prevention |  Journal of HPV and Cervical Cancer |  Journal of Cancer Research and Immuno-Oncology |  Journal of Cancer Science and Research |  Journal of Gastrointestinal Cancer and Stromal Tumors |  Journal of Infectious Diseases & Preventive Medicine |  Journal of Clinical & Experimental Dermatology Research |  Journal of Clinical Case Reports |  Journal of Clinical Trials |  Advanced Techniques in Biology & Medicine |  Biology and Medicine |  Journal of Stem Cell Research & Therapy |  Oncology & Cancer Case Reports |  Journal of Biomolecular Research & Therapeutics |  Hereditary Genetics: Current Research |  Journal of Molecular and Genetic Medicine |  Andrology-Open Access |  Journal of Molecular Biomarkers & Diagnosis |  Archives in Cancer Research |  Journal of Blood Disorders & Transfusion |  Journal of Carcinogenesis & Mutagenesis |  Chemotherapy: Open Access |  Journal of Clinical & Cellular Immunology |  Immunome Research |  Journal of Gastrointestinal & Digestive System |  International Journal of Inflammation, Cancer and Integrative Therapy |  Journal of Vaccines & Vaccination |  Journal of Blood & Lymph |  Journal of Cancer Science & Therapy |  Journal of Nursing & Care |  Journal of Integrative Oncology |  Journal of Leukemia |  Journal of Liver |  Reproductive System & Sexual Disorders: Current Research |  Pancreatic Disorders & Therapy |  Otolaryngology: Open Access |  Journal of Nuclear Medicine & Radiation Therapy |  Journal of Cancer Diagnosis |  Journal of Cancer Clinical Trials |  Colorectal Cancer: Open Access |  Head and Neck Cancer Research |  Cancer Surgery |  Journal of Prostate Cancer |  Journal of Genetic Syndromes & Gene Therapy |  JBR Journal of Clinical Diagnosis and Research |  Journal of Lung Cancer Diagnosis & Treatment |  Journal of Oncology Translational Research |  Journal of Clinical Respiratory Diseases and Care |  Reports in Cancer and Treatment |  Cancer Biology and Therapeutic Oncology

Clinical Research & Biomarkers Jobs in USA:

Clinical Trial Assistant | Watson Health Clinical Adoption Specialist - Medical Oncology | Field Clinical Manager, Neuromodulations | Clinical Research Coordinator | Research & Development - Associate Researcher | Sr CRA I Oncology | Associate Director Quality & Compliance | Specialist Associate | Clinic Assistant | Patient Service Associate | Associate / Clinical Research Coordinators | Research Fellow (Pharmacy) | Regional Study Coordinator | Medical Affairs Scientist | Clinical Trials Compliance Unit | Clinical Application Specialist | Technical Application Scientist | Medical Clinical & Observational Project Manager | Application Specialist (Ultrasound) | Manager Pathology | Specimen Processing (Junior/Senior) | Clinical Fellow (Medical Doctor) | Lab Officer/Senior Lab Officer (Cancer Research) | Cluster Medical Affairs Lead, South Asia | Medical Technologist II - Histology | Laboratory Manager/ Senior Laboratory Executive | In house clinical research associate |  clinical research associate | Senior Scientist, Oncology Biomarkers | Data Analyst II | Clinical Outsourcing Manager

Clinical Research & Biomarkers Jobs in Europe:

Statistician | Medical Writer | Statistician with Clinical Trials | Oncology Diagnostic SpecialistRA/SRA - In Vivo | In Vivo Cancer Pharmacology | Associate Director Medicinal Safety | Project Coordinator  | Bioanalysis Scientist | Marketing Director | Clinical Research Associate | Clinical Research Associate for Virtual Studies | Associate Editor, Plos one - Epidemiological, Clinical or Translational Research | Clinical Research Associate II | Boston Biomedical Associates (BBA) | Clinical Research RN | Columbia University Medical Center | Director, Clinical Research | Director, Clinical Research Protections & IRB Ops | Senior Director of Clinical Research and Pharmacovigilance | Clinical Nurse-Clinical Research Unit-Inpatient | Northwestern Memorial Hospital | Associate Medical Director/Medical Director, Clinical Research | Executive Director, Clinical Research & Medical Monitor

Clinical Research & Biomarkers Jobs in Asia-Pacific:

CBT Therapist | Clinical Research Medical Director, Neuroscience | Director Clinical Research, non MD - Oncology | Senior Director, Clinical Research Unit | Senior Director, Research | Head of Clinical Research & Development - Senior Medical Director |  Clinical Research Associate Oncology | Project Manager Regulatory Affairs | Head of Pharmacovigilance and Drug Safety | Senior Clinical Trial Manager (CNS) | Quality Assurance & Regulatory Affairs Professional | CQA Specialist, Pharmacovigilance | Clinical Operations Manager | Senior Regulatory Affairs Associate | Manager, Clinical Operations | Director QA Haemophilia & QP | Clinical and Pharmacovigilance Auditor | RA and Laboratory Manager | Senior Clinical Research Associate | (Senior) Director Project Delivery Early Phase Clinical Research | Clinical Operations Manager (FSP) | Associate Director | Director Regulatory Affairs, Strategy | Senior Pharmacovigilance Scientist | Site Quality Director Biologics | QA Compliance Specialist | Drug Safety Specialist | Senior Manager Regulatory Affairs Labeling

Past Conference Report

Clinical Research & Biomarkers 2018 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Clinical Research & Biomarkers 2018 Conference the successful!

8th Edition of International Conference on Clinical Research & Biomarkers 2018, hosted by the Euroscicon Ltd. was held during July 19-20, 2018 at Hotel Panorama, Prague, Czech Republic based on the theme “The Current Aspects and the Future of Clinical Research and Biomarkers" which got magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonish presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Clinical Research made this event a grand success. 

Euroscicon Ltd expresses its gratitude to the conference Moderator, namely Dr. Marina Guvakova, University of Pennsylvania, USA for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support. A very special thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum. The speakers list includes: 

Dr. Laurence Choulier, Université de Strasbourg, France
Dr. Kenji Izuhara, Saga Medical School, Japan
Dr. Youhe Gao, Beijing Normal University, China
Dr. Marina Guvakova, University of Pennsylvania, USA
Dr. Maysa Suyagh, The University of Jordan, Jordan
Dr. Nwayyin Najat Mohammed, The University of Sulaymaniyah, Iraq
Dr. Diana Foster, Total Clinical Trial Management, USA
Dr. Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
Dr. Zuzana Horakova, St. Annes University Hospital, Czech Republic
Dr. Suha Al Muhaissen, The University of Jordan, Jordan
Dr. Violet Kasabri, The University of Jordan, Jordan

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Biomarkers
  • Clinical Applications Of Biomarkers
  • Genomics Biomarkers
  • Transcriptional Profiling
  • Development Of Biomarkers
  • Biomarkers & Pathology
  • Biomarkers & Next-Generation Sequencing
  • Bioethics Regulatory Compliance
  • Biomarkers & Diseases
  • Current Researches & Innovations
  • Biomarkers In Drug Discovery & Development
  • Clinical Research & Clinical Trials
  • Biomarkers & Radiology
  • Case Reports
  • Biomarkers & Personalized Medicine
  • Biomarkers: Validation & Verification
  • Clinical Research & Methodology
  • Clinical Data Management & Analytics
  • Pharmacovigilance & Drug Safety
  • Biomarkers & Cancers
  • Careers In Clinical Research
  • CRO & Sponsorship
  • Research & Trials On HIV/Diabetes/ Cancer
  • Globalization Of Clinical Trial

Euroscicon Ltd also took the privilege of felicitating Clinical Research & Biomarkers 2018 Organizing Committee, Editorial Board Members of Biomarkers Journal and Annals of Clinical and Laboratory Research Journal, Keynote Speakers, Chair and Co-Chairs, Moderator and Exhibitor who supported this event. With the grand success of Clinical Research & Biomarkers 2018, Euroscicon Ltd is proud to announce the 9th Edition of International Conference on Clinical Research & Biomarkers 2019" to be held soon.

For More details visit: https://clinicalresearch.euroscicon.com/

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!